Skip to main content
Watch Insiders
LXEOHealthcare

Lexeo Therapeutics Inc. (LXEO) Insider Trading

In the last 90 days, 3 Lexeo Therapeutics Inc. (LXEO) insiders reported no open-market purchases and 3 sales totaling $43,228. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 18, 2026Louis Edward TamayoChief Financial OfficerSale4,117$4.91$20,203
Aug 18, 2026Jose Manuel OteroChief Operating OfficerSale1,304$4.96$6,464
Aug 18, 2026Richard Nolan TownsendChief Executive OfficerSale3,345$4.95$16,562
Jul 1, 2026Narinder Pal BhallaChief Medical OfficerSale22,306$4.42$98,593
Jul 1, 2026Louis Edward TamayoChief Financial OfficerSale4,641$4.49$20,838
Jul 1, 2026Jose Manuel OteroChief Operating OfficerSale4,666$4.48$20,904
Jul 1, 2026Richard Nolan TownsendChief Executive OfficerSale25,947$4.48$116,243
May 18, 2026Jose Manuel OteroChief Operating OfficerSale1,302$5.07$6,606
May 18, 2026Richard Nolan TownsendChief Executive OfficerSale3,342$5.06$16,927

Common questions

LXEO insider trading FAQ

Are LXEO insiders buying or selling?
Over the last 90 days, LXEO insiders were net sellers, reporting $0.00 of open-market purchases and $43,228 of sales.
When was the last LXEO insider purchase?
No open-market insider purchase of Lexeo Therapeutics Inc. stock was reported in the last 90 days.
Where does LXEO insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Lexeo Therapeutics Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.